• Mon news: Ventyx gets boost from Sanofi. PhRMA IRA legal challenge gets new life. AZ breast cancer drug disappoints. Teva’s once-monthly schizophrenia med. AZ gets FDA approval for first self-administered flu vaccine. See more on our front page

Gilead partnering with Cartography Biosciences to discover cancer therapies

cafead

Administrator
Staff member
  • cafead   May 28, 2024 at 10:42: AM
via Gilead Sciences (NASDAQ:GILD) has agreed to collaborate with Cartography Biosciences to develop new therapies for triple-negative breast cancer and adenocarcinoma, the most common form of non-small cell lung cancer.

article source
 

<